Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2024
Warning Letter Issued Over Subsidiary's Use of Non-Company Account to Collect Sales Deposits
In 2024, the Hunan Securities Regulatory Bureau determined that Jiuzhitang's subsidiary Mudanjiang Bobo used a non-company bank account to collect deposits for sales agency rights for Shuxuetong Injection from 2022 to 2024, and that there were related information disclosure issues. The company and relevant personnel were issued warning letters. This was an administrative regulatory measure, not a criminal judgment.